Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 PatientsMartin Spahn, Steven Joniau, Paolo Gontero et al.|European Urology|2010Cited by 154
Pretreatment Tables Predicting Pathologic Stage of Locally Advanced Prostate CancerSteven Joniau, Paolo Gontero, D. Frohneberg et al.|European Urology|2014Cited by 38
Efficacy and Safety of Tadalafil 20 mg on Demand vs. Tadalafil 5 mg Once-a-Day in the Treatment of Post-Radiotherapy Erectile Dysfunction in Prostate Cancer Men: A Randomized Phase II TrialUmberto Ricardi, A Tizzani, Paolo Gontero et al.|The Journal of Sexual Medicine|2010Cited by 32
Is there a prostate‐specific antigen upper limit for radical prostatectomy?Paolo Gontero, Steven Joniau, Martin Spahn et al.|British Journal of Urology|2011Cited by 25
7012 Evaluation of the efficacy and safety of Tadalafil 20 mg on demand vs Tadalafil 5 mg once-a-day in the treatment of erectile dysfunction following curative radiotherapy for prostatic carcinoma: preliminary results of a randomized phase II trialPatrizia Ciammella, Umberto Ricardi, Serena Badellino et al.|European Journal of Cancer Supplements|2009Cited by 2